Cell ther­a­py start­up Au­ri­on files for IPO, de­spite on­go­ing le­gal bat­tle with in­vestor Al­con

In­vestors typ­i­cal­ly cel­e­brate IPOs as mile­stone mo­ments — and po­ten­tial ex­it op­por­tu­ni­ties — for their star­tups.

In an un­usu­al twist, the eye gi­ant Al­con has tak­en a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER